Most lately, it has been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to your wide array of endogenous opioids. Not like most opioid receptors, this receptor acts being a scavenger https://annelii457fui4.blogozz.com/profile